|
4NDM
Structure of the AB18.1 TCR
Deposited 2013-10-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
118–220(103 aa)
Fragment:AB18.1 TCR delta chain
|
Mutation:T167C
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;292 K;20% PEG3350, 0.2 M trisodium citrate, 2% Ethylene Glycol, VAPOR DIFFUSION, SITTING DROP, temperature 292K
|
Resolution 3.01 Å
R-free 0.280
|
|
4ZAK
Crystal structure of the mCD1d/DB06-1/iNKTCR ternary complex
Deposited 2015-04-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
4LX N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanethioamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;295 K;20% PEG 4000, 0.2M ammonium citrate dibasic
|
Resolution 2.82 Å
R-free 0.256
|
|
5E6I
Crystal structure of TCR PF8 in complex with flu MP(58-66) epitope presented by HLA-A2
Deposited 2015-10-09
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain G
116–210(95 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.1M immidazole pH8, 0.2M calcium acetate, 10%(v/v) PEG8000
|
Resolution 4.00 Å
R-free 0.338
|
|
5E6I
Crystal structure of TCR PF8 in complex with flu MP(58-66) epitope presented by HLA-A2
Deposited 2015-10-09
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
116–210(95 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.1M immidazole pH8, 0.2M calcium acetate, 10%(v/v) PEG8000
|
Resolution 4.00 Å
R-free 0.338
|
|
5E6I
Crystal structure of TCR PF8 in complex with flu MP(58-66) epitope presented by HLA-A2
Deposited 2015-10-09
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain F
116–210(95 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.1M immidazole pH8, 0.2M calcium acetate, 10%(v/v) PEG8000
|
Resolution 4.00 Å
R-free 0.338
|
|
5E6I
Crystal structure of TCR PF8 in complex with flu MP(58-66) epitope presented by HLA-A2
Deposited 2015-10-09
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain P
116–210(95 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.1M immidazole pH8, 0.2M calcium acetate, 10%(v/v) PEG8000
|
Resolution 4.00 Å
R-free 0.338
|
|
5MEN
Human Leukocyte Antigen A02 presenting ILAKFLHWL, in complex with cognate T-Cell Receptor
Deposited 2016-11-16
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
118–206(89 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 5
GOL GLYCEROL × 1
SO4 SULFATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2M ammonium sulphate, 0.1M HEPES pH7, 20% PEG 8000
|
Resolution 2.81 Å
R-free 0.272
|
|
5VCJ
Structure of alpha-galactosylphytosphingosine bound by CD1d and in complex with the Va14Vb8.2 TCR
Deposited 2017-03-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
Fragment:UNP A0A0B4J1J9 residues 22-114,UNP K7N5M3 residues 116-210
|
Not recorded
|
N57 (2S,3S,4R)-2-amino-3,4-dihydroxyoctadecyl alpha-D-galactopyranoside × 1
PLM PALMITIC ACID × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;295 K;20 % polyethylene glycol 3350, 200 mM sodium malonate
|
Resolution 3.16 Å
R-free 0.248
|
|
5WLG
Crystal Structure of H-2Db with the GAP501 peptide (SQL)
Deposited 2017-07-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
118–194(77 aa)
|
Not recorded
|
NA SODIUM ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.2;277 K;18%PEG3350, 2% ethylen glycol, 0.2M CaCl2, 0.1M HEPES pH 7.2
|
Resolution 2.10 Å
R-free 0.249
|
|
5WLG
Crystal Structure of H-2Db with the GAP501 peptide (SQL)
Deposited 2017-07-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain I
118–194(77 aa)
|
Not recorded
|
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.2;277 K;18%PEG3350, 2% ethylen glycol, 0.2M CaCl2, 0.1M HEPES pH 7.2
|
Resolution 2.10 Å
R-free 0.249
|
|
6CW6
Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR
Deposited 2018-03-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
96–210(115 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
PBS (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA-D-GALACTOPYRANOSYL)OXY]-2-AMINO-OCTADECANE-3,4-DIOL × 1
PLM PALMITIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;295 K;8% Tacsimate pH 4.0
20% PEG 3350
|
Resolution 2.85 Å
R-free 0.250
|
|
6D78
The complex between high-affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with the bound MART-1(27-35)peptide
Deposited 2018-04-24
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
118–206(89 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;0.1 M Tris, 12% PEG6000, 0.2 M magnesium chloride
|
Resolution 2.35 Å
R-free 0.255
|
|
6MIV
Crystal structure of the mCD1d/xxq (JJ300)/iNKTCR ternary complex
Deposited 2018-09-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
NA SODIUM ION × 3
GOL GLYCEROL × 4
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
JU1 N-[(2S,3S,4R)-1-({4-O-[(4-tert-butylphenyl)methyl]-alpha-D-galactopyranosyl}oxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;295 K;0.1 m sodium malonate pH 4.0, 12% PEG 3350
|
Resolution 2.05 Å
R-free 0.219
|
|
6MIY
Crystal structure of the mCD1d/xxa (JJ239)/iNKTCR ternary complex
Deposited 2018-09-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
NA SODIUM ION × 2
CL CHLORIDE ION × 1
JTV N-{(2S,3S,4R)-1-[(4-O-benzyl-alpha-D-galactopyranosyl)oxy]-3,4-dihydroxyoctadecan-2-yl}hexacosanamide × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2 m ammonium tartrate dibasic, 20% PEG 4000
|
Resolution 2.75 Å
R-free 0.247
|
|
6MIY
Crystal structure of the mCD1d/xxa (JJ239)/iNKTCR ternary complex
Deposited 2018-09-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain G
116–210(95 aa)
|
Not recorded
|
NA SODIUM ION × 2
JTV N-{(2S,3S,4R)-1-[(4-O-benzyl-alpha-D-galactopyranosyl)oxy]-3,4-dihydroxyoctadecan-2-yl}hexacosanamide × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2 m ammonium tartrate dibasic, 20% PEG 4000
|
Resolution 2.75 Å
R-free 0.247
|
|
6MJ4
Crystal structure of MCD1D/INKTCR TERNARY COMPLEX bound to glycolipid (XXW)
Deposited 2018-09-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
GOL GLYCEROL × 6
NA SODIUM ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
JTG N-[(2S,3S,4R)-3,4-dihydroxy-1-{[4-O-(prop-2-en-1-yl)-alpha-D-galactopyranosyl]oxy}octadecan-2-yl]hexacosanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.1 m sodium malonate pH 4.0, 12% PEG 3350
|
Resolution 2.00 Å
R-free 0.214
|
|
6MJ6
Crystal structure of the mCD1d/xxx (JJ166) /iNKTCR ternary complex
Deposited 2018-09-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
GOL GLYCEROL × 7
NA SODIUM ION × 3
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
JTM N-[(2S,3S,4R)-1-({4-O-[(4-chlorophenyl)methyl]-alpha-D-galactopyranosyl}oxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.1 m sodium malonate pH 4.0, 12% PEG 3350
|
Resolution 2.45 Å
R-free 0.234
|
|
6MJA
Crystal structure of the mCD1d/xxo (JJ294) /iNKTCR ternary complex
Deposited 2018-09-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
NA SODIUM ION × 2
GOL GLYCEROL × 3
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
JTJ N-[(2S,3S,4R)-3,4-dihydroxy-1-({4-O-[(4-methylphenyl)methyl]-alpha-D-galactopyranosyl}oxy)octadecan-2-yl]hexacosanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2 m ammonium tartrate dibasic, 20% PEG 4000
|
Resolution 2.35 Å
R-free 0.237
|
|
6MJI
Crystal structure of the mCD1d/xxs (JJ304) /iNKTCR ternary complex
Deposited 2018-09-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
NA SODIUM ION × 2
GOL GLYCEROL × 6
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
JTD N-[(2S,3S,4R)-1-{[4-O-(cyclopropylmethyl)-alpha-D-galactopyranosyl]oxy}-3,4-dihydroxyoctadecan-2-yl]hexacosanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.1 m sodium malonate pH 4.0, 12% PEG 3350
|
Resolution 2.30 Å
R-free 0.227
|
|
6MJJ
Crystal structure of the mCD1d/xxm (JJ290) /iNKTCR ternary complex
Deposited 2018-09-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
GOL GLYCEROL × 10
NA SODIUM ION × 9
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
JU4 N-[(2S,3S,4R)-1-({4-O-[(3,4-dichlorophenyl)methyl]-alpha-D-galactopyranosyl}oxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.1 m sodium malonate pH 4.0, 12% PEG 3350
|
Resolution 1.93 Å
R-free 0.216
|
|
6MJQ
Crystal structure of the mCD1d/xxp (JJ295) /iNKTCR ternary complex
Deposited 2018-09-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
GOL GLYCEROL × 1
NA SODIUM ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
JUD N-{(2S,3S,4R)-3,4-dihydroxy-1-[(4-O-{[4-(trifluoromethyl)phenyl]methyl}-alpha-D-galactopyranosyl)oxy]octadecan-2-yl}hexacosanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.1 m sodium malonate pH 4.0, 12% PEG 3350
|
Resolution 3.00 Å
R-free 0.258
|
|
6MJQ
Crystal structure of the mCD1d/xxp (JJ295) /iNKTCR ternary complex
Deposited 2018-09-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain G
116–210(95 aa)
|
Not recorded
|
GOL GLYCEROL × 2
NA SODIUM ION × 2
JUD N-{(2S,3S,4R)-3,4-dihydroxy-1-[(4-O-{[4-(trifluoromethyl)phenyl]methyl}-alpha-D-galactopyranosyl)oxy]octadecan-2-yl}hexacosanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.1 m sodium malonate pH 4.0, 12% PEG 3350
|
Resolution 3.00 Å
R-free 0.258
|
|
6R2L
NYBR1-A2-SLSKILDTV
Deposited 2019-03-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
118–198(81 aa)
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 1
EDO 1,2-ETHANEDIOL × 2
GOL GLYCEROL × 3
SO4 SULFATE ION × 8
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;291 K;0.2 M NaCl, 0.1 M MES, 20% PEG 6000, pH 6.0 . Condition B07 from Molecular Dimensions PACT premier HT-96/FX-96, MD1-36
|
Resolution 2.30 Å
R-free 0.265
|
|
6V80
Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
Deposited 2019-12-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
96–210(115 aa)
|
Not recorded
|
AGH N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;21 % (v/v) PEG 3350, 0.2 M tri-sodium citrate, 3% (v/v) D-(+)-trehalose dehydrate
|
Resolution 3.53 Å
R-free 0.254
|
|
6V80
Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
Deposited 2019-12-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain H
96–210(115 aa)
|
Not recorded
|
AGH N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;21 % (v/v) PEG 3350, 0.2 M tri-sodium citrate, 3% (v/v) D-(+)-trehalose dehydrate
|
Resolution 3.53 Å
R-free 0.254
|
|
8T4Z
T-cell receptor and lipid complex structure
Deposited 2023-06-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
116–210(95 aa)
|
Not recorded
|
Y73 N-[(2R,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]tetracosanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;18-20% PEG3350, 8% Tacsimate pH 5.0
|
Resolution 2.69 Å
R-free 0.265
|